You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Docetaxel albumin-bound

Showing 1 - 25 of 4,214
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

Recruiting
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Gastroesophageal Junction
  • Docetaxel for injection (Albumin-bound)
  • Taxotere
  • Guangzhou, China
    Ethics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Pancreatic Cancer Trial in Shanghai (Docetaxel for injection (Albumin-bound))

Not yet recruiting
  • Pancreatic Cancer
  • Docetaxel for injection (Albumin-bound)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 13, 2022

Platinum-resistant Recurrent Ovarian Cancer Trial in Wuhan (Docetaxel for injection (Albumin-bound), Bevacizumab)

Recruiting
  • Platinum-resistant Recurrent Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital,Tongji Medical College of HUST
Oct 12, 2022

Advanced Solid Tumors Trial in Cangzhou (Docetaxel for Injection (Albumin-bound), Taxotere)

Active, not recruiting
  • Advanced Solid Tumors
  • Docetaxel for Injection (Albumin-bound)
  • Taxotere
  • Cangzhou, China
    Cangzhou Central Hospital
Jan 27, 2022

Advanced Solid Tumors Trial in Chengdu (Albumin-bound docetaxel)

Recruiting
  • Advanced Solid Tumors
  • Albumin-bound docetaxel
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jan 27, 2022

Advanced Solid Tumors Trial in Shijiazhuang (Albumin-bound docetaxel)

Recruiting
  • Advanced Solid Tumors
  • Albumin-bound docetaxel
  • Shijiazhuang, Hebei, China
    Liu yunjiang
Jan 27, 2022

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Docetaxel, Nivolumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, Shanghai, China
    Guo Ye
Jan 27, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Cancer Trial in China (Albumin-bound paclitaxel combined with carboplatin, Epirubicin combined with docetaxel)

Recruiting
  • Breast Cancer
  • Albumin-bound paclitaxel combined with carboplatin
  • Epirubicin combined with docetaxel
  • Harbin, Heilongjiang, China
  • +6 more
Jul 18, 2021

Breast Cancer Trial in Shanghai (Albumin-bound paclitaxel plus capecitabine, capecitabine)

Recruiting
  • Breast Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer center
Mar 2, 2021

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Tianjin (albumin-bound paclitaxel)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • albumin-bound paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Feb 19, 2021

Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

Not yet recruiting
  • Gastric Adenocarcinoma
  • cadonilimab combined +paclitaxel (albumin-bound)
  • (no location specified)
Nov 1, 2023

Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • Xi'an, Shaanxi, China
    Hongxi Zhao
Sep 20, 2023

Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
  • Gemcitabine hydrochloride and albumin binding paclitaxel
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Dec 8, 2022

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

Not yet recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
  • (no location specified)
Jul 9, 2023

Advanced Breast Cancer Trial in Shijia Zhuang (SYHX2011, Paclitaxel for injection (albumin-bound))

Not yet recruiting
  • Advanced Breast Cancer
  • SYHX2011
  • Paclitaxel for injection (albumin-bound)
  • Shijia Zhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Feb 22, 2023

Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) Trial in Beijing (Sirolimus for Injection (Albumin Bound))

Recruiting
  • Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
  • Sirolimus for Injection (Albumin Bound)
  • Beijing, China
    Beijing Jishuitan Hospital
Nov 23, 2022

Breast Cancer Trial in China (JSKN003, Capecitabine tablets, Gemcitabine HCl for injection)

Not yet recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
  • +49 more
Oct 6, 2023

Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))

Not yet recruiting
  • Malignant Solid Tumors
  • Sirolimus for Injection (Albumin-bound)
  • (no location specified)
Aug 19, 2022

Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
  • Albumin-bound Paclitaxel
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Jan 21, 2023